ISMD and IBD Related Headlines
Go Back- Inspire Investing Announces Lower Expense Ratios on 5 Faith-Based ETFs
- 0.09% Biblically Responsible ETF Outperforms S&P 500 Index in Two Years Since Launch
- Inspire Named to Inc.'s 2026 List of Fastest-Growing Private Companies in the Rocky Mountains
- Inspire Surpasses $4 Billion in Assets Under Management
- Inspire Growth ETF (NYSE: GLRY) Celebrates 5-Year Anniversary and 5-Star Morningstar Rating
- Inspire Fidelis Multi-Factor ETF (FDLS) Receives Prestigious 5-Star Overall Morningstar Rating™
- Inspire Investing Announces Fund Name Changes to Better Reflect Growth and Capital Appreciation Strategies
- Inspire Investing Earns Great Place To Work Certification™ for Third Consecutive Year
- Inspire Fidelis Multi Factor ETF (NYSE: FDLS) Celebrates 3-Year Anniversary, Surpasses $100 Million in AUM
- Inspire Makes Inc. 5000 List for Sixth Year in A Row
ISMD and IBD Related Press Releases
Go Back- Inspire Investing Announces Lower Expense Ratios on 5 Faith-Based ETFs
- 0.09% Biblically Responsible ETF Outperforms S&P 500 Index in Two Years Since Launch
- Inspire Named to Inc.'s 2026 List of Fastest-Growing Private Companies in the Rocky Mountains
- Inspire Surpasses $4 Billion in Assets Under Management
- Inspire Growth ETF (NYSE: GLRY) Celebrates 5-Year Anniversary and 5-Star Morningstar Rating
- Inspire Fidelis Multi-Factor ETF (FDLS) Receives Prestigious 5-Star Overall Morningstar Rating™
- Inspire Investing Announces Fund Name Changes to Better Reflect Growth and Capital Appreciation Strategies
- Inspire Investing Earns Great Place To Work Certification™ for Third Consecutive Year
- Inspire Fidelis Multi Factor ETF (NYSE: FDLS) Celebrates 3-Year Anniversary, Surpasses $100 Million in AUM
- Inspire Makes Inc. 5000 List for Sixth Year in A Row
